COMMUNIQUÉS West-GlobeNewswire
-
Ipsen annonce avec une profonde tristesse le décès de Henri Beaufour, membre de son conseil d'administration issu de la famille fondatrice
01/12/2025 -
Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision
30/11/2025 -
Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform
30/11/2025 -
At RSNA 2025, ASCEND Cardiovascular and Konica Minolta Healthcare Announce Partnership to Deliver a Best-in-Class Enterprise Imaging Solution that Elevates Cardiovascular Care
30/11/2025 -
Konica Minolta Healthcare Launches New Floor-Mounted Digital Radiography Systems at RSNA 2025
30/11/2025 -
DeepHealth Unveils Next-Generation Imaging Informatics and Clinical AI Solutions at RSNA 2025, Advancing a New Standard of AI-Powered Care
30/11/2025 -
Anabolic Steroids Alternatives: Muscle Building Supplements from CrazyBulk | Most Selling Muscular Endurance Supplements Bodybuilders Use For Peak Performance & Strength Building in 2025
29/11/2025 -
Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program
29/11/2025 -
Algernon Closes Second Tranche of Private Placement Financing
29/11/2025 -
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
28/11/2025 -
INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”
28/11/2025 -
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
28/11/2025 -
NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update
28/11/2025 -
PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference
28/11/2025 -
Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
28/11/2025 -
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/11/2025 -
Hydreight Technologies Acquires 5% Equity Stake in Perfect Scripts, LLC, with Option to Increase up to 40%, and Establishes Strategic Partnership
28/11/2025 -
Boehringer Ingelheim announces appointment to Board of Managing Directors
28/11/2025 -
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
28/11/2025
Pages